Successful treatment of high-risk gestational trophoblastic disease in a patient with intolerance to standard chemotherapy (clinical case)

• Autores principales: G. M. Teletaeva (Autor), E. A. Ulrikh (Autor), D. Kh. Latipova (Autor), A. I. Semenova (Autor), E. V. Levchenko (Autor), D. G. Ulrikh (Autor), I. V. Berlev (Autor), T. Yu. Semiglazova (Autor), S. A. Protsenko (Autor), A. F. Urmancheeva (Autor)
• Formato: Libro
• Publicado: ABV-press, 2021-01-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Gestational trophoblastic disease is a rare tumor highly sensitive to systemic drug therapy. The standard regimens of chemotherapy of I and II lines for patients in the high-risk group for gestational trophoblastic disease are the EMA-CO, EMA-EP and TP/TE regimens, which have been demonstrated to be...